Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease

Parkinson's patients had a distinct, potentially pro-inflammatory microbiota in the deep nasal sinus cavity near the olfactory bulb. Moraxella catarrhalis was enriched in patients and correlated with more severe motor scores, while short-chain-fatty-acid-producing bacteria were reduced.

2026-07-05

Alterations of gut microbiome in autoimmune hepatitis

In 91 steroid-naive autoimmune hepatitis patients, the gut microbiome had lower diversity, depleted anaerobes, and expanded pathobionts including Veillonella, which correlated with aspartate aminotransferase and liver inflammation; a four-genus panel separated patients from controls with about 0.8 accuracy.